Skip to content

Application of PNE in Postoperative Pain Management of Patients With Primary Total Knee Arthroplasty

Application of PNE in Postoperative Pain Management of Patients With Primary Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05915650
Enrollment
70
Registered
2023-06-23
Start date
2020-12-01
Completion date
2021-12-01
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

This study intends to carry out pain neuroscience education intervention for TKA patients to clarify the effect of this method on the degree of postoperative pain, the incidence of pain catastrophizing, kinesiophobia, and knee joint function rehabilitation in TKA patients, so as to provide a basis for clinical nursing of such patients.

Interventions

Carry out routine education intervention for TKA patients

BEHAVIORALPain Neuroscience Education

Carry out pain neuroscience education intervention for TKA patients

Sponsors

Zunyi Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

1. Patients diagnosed as KOA according to the criteria and undergoing unilateral total knee arthroplasty for the first time; 2. The subjects included in this study were men or women aged 45-74 years; 3. Clear self-cognition, can browse the text by themselves or can answer questions correctly; 4. Those who voluntarily participated in the study and signed an informed consent form after understanding the relevant information of the study; 5. Without serious physical diseases such as heart, liver or kidney; 6. No history of mental illness or drug dependence.

Exclusion criteria

1. Combined with severe trauma in other parts; 2. Accompanied by serious damage to other organs, such as heart and cerebrovascular diseases, lung and kidney diseases; 3. Patients with knee tumor and severe knee deformity who could not complete the rehabilitation; 4. With neurological diseases that limit physical activity; 5. Participating in other investigators during the same period.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale pain score, (VAS)3 months after dischargeStatus of pain

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026